search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • News
  • News & Events
  • News
  • Cancer researcher Piet Borst to receive honorary doctorate from the University of Bern, Switzerland

Cancer researcher Piet Borst to receive honorary doctorate from the University of Bern, Switzerland

06-12-2019

On Saturday, December 7, the University of Bern will award an honorary doctorate to Piet Borst, staff member and former director of the Netherlands Cancer Institute. Dr. Borst is also an emeritus professor of clinical biochemistry and molecular biology at the University of Amsterdam. 

Borst P

Borst will be awarded a doctorate for his ground-breaking research into cellular organelles such as mitochondria, sleeping sickness pathogens, the drug resistance of cancer cells, and for his contributions to research and research assessment in Switzerland. He has a long-standing history with the city of Bern. It was the site of his cooperation with parasitologists in the 1980s, and the university awarded him the Dr Albert Wander Prize in 1990. The prize was also known as the "heisse Ovi Preis" because Wander earned a living by producing and selling Ovomaltine.

In recent years Dr. Borst worked closely with Professor Sven Rottenberg, a former postdoc in the Borst group, now a professor in Bern. This cooperation is a continuation of the study into chemotherapy resistance, initiated by Rottenberg during his time in the Borst Group at the Netherlands Cancer Institute. Borst was a co-supervisor for a PhD candidate who was under the supervision of Rottenberg, and he also frequently contributed to the assessment of grant applications at the Bern headquarters of the Swiss counterpart to the Netherlands Organization for Scientific Research (NWO).

Dr. Borst was previously awarded honorary doctorates by the Universities of Dundee, Scotland, and Leiden, the Netherlands. ​

Other tumors

Support our science?

Learn more

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.